Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I1LR
|
||||
Former ID |
DNC005259
|
||||
Drug Name |
2-morpholin-4-yl-8-thiophen-3-ylchromen-4-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527888] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H15NO3S
|
||||
Canonical SMILES |
C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CSC=C4
|
||||
InChI |
1S/C17H15NO3S/c19-15-10-16(18-5-7-20-8-6-18)21-17-13(2-1-3-14(15)17)12-4-9-22-11-12/h1-4,9-11H,5-8H2
|
||||
InChIKey |
MHMBRJOWOVNUNC-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | DNA-dependent protein kinase catalytic subunit | Target Info | Inhibitor | [527888] | |
KEGG Pathway | Non-homologous end-joining | ||||
Cell cycle | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
Reactome | Nonhomologous End-Joining (NHEJ) | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.